Indivior Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Indivior Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $195.00 million for the year ending 2025.

  • Indivior Pharmaceuticals, Inc. showed a decrease of -38.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Indivior Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Indivior Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 38.3%.
  • Historical annual values: Fiscal year 2025: $195.00 million | Fiscal year 2024: $319.00 million | Fiscal year 2023: $316.00 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: